GLP-1s (glucagon-like peptide-1 receptor agonists) are prescription medications that help regulate blood sugar, appetite, and metabolism. They’re FDA-approved for type 2 diabetes and, in some cases, chronic weight management. MedChoice offers compounded semaglutide or tirzepatide. These formulations are prepared by licensed U.S. compounding pharmacies which are LegitScript certified.

Please note: Compounded medications are not FDA-approved and may differ in formulation, safety, and effectiveness from brand-name drugs like Ozempic or Zepbound. All prescriptions are reviewed by licensed providers.

Eligibility is determined through a clinical intake and consult. You may not be eligible for GLP-1 treatment if you have:

• A personal or family history of medullary thyroid carcinoma (MTC)
• A diagnosis of Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• A known allergy or hypersensitivity to GLP-1 medications or their components
• Are currently pregnant or breastfeeding
• A history of pancreatitis
• Severe gastrointestinal disorders, including gastroparesis
• Diabetic retinopathy or other advanced eye disease
• Gallbladder disease or a history of gallstones
• Mood disorders or eating disorders that may be impacted by appetite suppression

We screen carefully to ensure safety and compliance with FDA guidelines.

Remember: If the provider determines it is unsafe for you to receive GLP-1 treatment, you will be refunded the amount you paid for the medication.

• Start Here! your package and submit payment; complete the intake form
• You will receive a link to meet with a licensed provider via video
• The licensed provider will review your information with you
• If you are eligible to receive GLP-1 treatment, the medication and supplies will be shipped to your door — no shipping fees
• Ongoing support and refills are available

No, our services are cash-pay only. However, many patients use HSA/FSA funds. We provide receipts for reimbursement if applicable.

Common side effects include nausea, constipation, and fatigue. Serious risks are rare but include pancreatitis and thyroid tumors. We monitor for red flags during intake.

All consults are conducted by board-certified and licensed providers. We follow state-specific telehealth regulations and maintain collaborative agreements where required.

We currently serve patients in all states except Mississippi and Alabama.

Absolutely. We use HIPAA-compliant platforms and never share your data without consent.